Emerging therapies in rosacea

详细信息    查看全文

• 作者：Alison Layton ; Diane Thiboutot
• 关键词：carvedilol ; ivermectin ; medical therapy ; permethrin ; rosacea ; subantimicrobial-dose doxycycline
• 刊名：Journal of the American Academy of Dermatology
• 出版年：December, 2013
• 年：2013
• 卷：69
• 期：6_supp_S1
• 页码：S57-S65
• 全文大小：1409 K

文摘

Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients.